| Authors: |
Ayloo S; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Ryu JC; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Chou SC; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Blatnik L; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Wischhof E; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Bu J; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Guo L; Translational Medicine Unit, Sanofi, Cambridge, MA 02141, USA., Hossain M; Translational Medicine Unit, Sanofi, Cambridge, MA 02141, USA., Ghosh D; Translational Medicine Unit, Sanofi, Cambridge, MA 02141, USA., McCarty W; Quantitative Pharmacology, Sanofi, Cambridge, MA 02141, USA., Byrne A; Target Disease and Systems Biology, Cambridge, MA 02141, USA., Chai L; Target Disease and Systems Biology, Cambridge, MA 02141, USA., Clarke J; Rare Diseases TA, Sanofi, Cambridge, MA 02141, USA., Kayatekin C; Rare Diseases TA, Sanofi, Cambridge, MA 02141, USA., Zhang B; Translational Medicine Unit, Sanofi, Cambridge, MA 02141, USA., Sardi SP; Rare Diseases TA, Sanofi, Cambridge, MA 02141, USA., Goulet M; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Elmer B; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA., Mueller C; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA. Electronic address: gmu@sanofi.com., Ramachandran S; Genomic Medicine Unit, Sanofi, Waltham, MA 02451, USA. |
